Featured articles from the journal CHEST®, April 2023

Published monthly, the journal CHEST^® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The April issue of the CHEST journal contains 50 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia resources, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“With April serving as Sarcoidosis Awareness Month, I recommend reading the latest research, “Efzofitimod for the Treatment of Pulmonary Sarcoidosis,” included in the April issue,” says Editor-in-Chief of the journal, Peter Mazzone, MD, MPH, FCCP. “While larger studies are needed, this research suggests that efzofitimod may be a useful treatment to manage sarcoidosis.”

Also included in the current issue of the journal CHEST:

• Asthma

Cross-sectional study, “Peripheral Airway Dysfunction in Obesity and Obese Asthma,” finds that people with obesity and asthma have significant dysfunction in the distal airways at baseline that worsens with methacholine.

• Critical Care

Qualitative analysis, “Multidisciplinary ICU Recovery Clinic Visits,” identifies two primary themes from the patient-provider dialogue: problem identification and problem-solving strategies. View the visual abstract for this research.

• Sleep

Original research, “OSA and Subsequent Risk of Hospitalization With Pneumonia, Respiratory Infection, and Total Infection,” suggests screening for and treating severe OSA in the primary care setting may lower the risk of hospitalization caused by pneumonia and other infectious diseases. View the visual abstract for this research.

• Thoracic Oncology

“Shape-Sensing Robotic-Assisted Bronchoscopy vs Digital Tomosynthesis-Corrected Electromagnetic Navigation Bronchoscopy” uses a uniform conservative definition of diagnostic yield to show that diagnostic performance and safety profiles were comparable for shape-sensing robotic-assisted bronchoscopy and digital tomosynthesis-electromagnetic navigational bronchoscopy. Listen to a podcast of the experts discussing their findings.

---

Notes for editors

To view the entire April issue of CHEST journal (volume 163, issue 4), published by Elsevier, visit journal.chestnet.org and follow @journal_CHEST on Twitter for the latest journal news.

Full text of these articles and interviews with the authors are available to credentialed journalists upon request; contact Laura DiMasi, PR and Communications Specialist, American College of Chest Physicians (CHEST), at [email protected].

About the journal CHEST^®

The journal CHEST, the official publication of the American College of Chest Physicians®, features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care, and sleep medicine; thoracic surgery; cardiorespiratory interactions; and related disciplines. Published since 1935, it is home to the highly regarded clinical practice guidelines and consensus statements. Access the journal CHEST online at journal.chestnet.org.

About the American College of Chest Physicians

The American College of Chest Physicians^® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care, and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST^®, visit chestnet.org.

About Elsevier

Elsevier is a global leader in advanced information and decision support. For over a century, we have been helping advance science and healthcare to advance human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals and educators across 170 countries in their vital work. We do this by delivering mission-critical insights and innovative solutions that combine trusted, evidence-based scientific and medical content with cutting-edge AI technologies to help impact makers achieve better outcomes. We champion inclusion and sustainability by embedding these values into our products and culture, working with the communities that we serve. The Elsevier Foundation supports research and health partnerships around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.elsevier.com and follow us on social media @ElsevierConnect.